| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 13 | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 13 | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 13 | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 13 | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 17 | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 17 | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 17 | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 10, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 17 | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 17 | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 17 | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 17 | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 17 | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 10, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6 | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 16.8 | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 16.8 | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 16.8 | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 16.8 | Sep 30, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 11 | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 11 | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 11 | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 9, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 10, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 13.2 | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 13.2 | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 13.2 | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 10, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 10, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 10, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 10, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 10, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 10, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 10, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 10, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |